scholarly article | Q13442814 |
P819 | ADS bibcode | 2016PLoSO..1168170S |
P356 | DOI | 10.1371/JOURNAL.PONE.0168170 |
P932 | PMC publication ID | 5156407 |
P698 | PubMed publication ID | 27973612 |
P50 | author | Christophe Mas | Q47431850 |
P2093 | author name string | Monika Kuciak | |
Isabel Borges | |||
Karsten Siems | |||
Jens Mueller | |||
Ariel Ruiz I Altaba | |||
Chandan Seth | |||
Arwen Conod | |||
P2860 | cites work | Withanolides fromWithania adpressa | Q58865000 |
BMP signaling promotes the growth of primary human colon carcinomas in vivo | Q82555924 | ||
Attenuation of the Wnt/beta-catenin/TCF pathway by in vivo interferon-alpha2b (IFN-alpha2b) treatment in preneoplastic rat livers | Q82678049 | ||
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling | Q24316697 | ||
Histone modifications at human enhancers reflect global cell-type-specific gene expression | Q28238467 | ||
Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia | Q28302174 | ||
Interplay between chromatin-modifying enzymes controls colon cancer progression through Wnt signaling | Q28302972 | ||
The ID proteins: master regulators of cancer stem cells and tumour aggressiveness | Q28306121 | ||
Cancer epigenetics: from mechanism to therapy | Q29614799 | ||
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer | Q29616163 | ||
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment | Q29618024 | ||
H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells | Q30619629 | ||
The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks | Q33507753 | ||
Repressor activity of Headless/Tcf3 is essential for vertebrate head formation. | Q33601669 | ||
The central role of EED in the orchestration of polycomb group complexes. | Q33815083 | ||
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12. | Q33991455 | ||
Retracted: Bak Compensated for Bax in p53-null Cells to Release Cytochrome c for the Initiation of Mitochondrial Signaling during Withanolide D-Induced Apoptosis | Q34222357 | ||
Molecular insight in the multifunctional activities of Withaferin A. | Q34299843 | ||
Fusion of ZMYND8 and RELA genes in acute erythroid leukemia | Q34718336 | ||
The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. | Q34880355 | ||
Beta-catenin hits chromatin: regulation of Wnt target gene activation | Q34967116 | ||
Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination. | Q34981653 | ||
A New Golden Age of Natural Products Drug Discovery | Q35861508 | ||
Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion | Q36042084 | ||
Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas | Q36088885 | ||
Mining the Wnt pathway for cancer therapeutics | Q36670448 | ||
SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing β-catenin biosynthesis | Q36870110 | ||
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α | Q36926447 | ||
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. | Q37395251 | ||
Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells | Q37397036 | ||
Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin | Q37488585 | ||
Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis | Q37710265 | ||
Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda | Q38023388 | ||
Natural compounds with Wnt signal modulating activity | Q38591238 | ||
Antiproliferative effects of withanolides from Withania adpressa | Q38855715 | ||
Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A. | Q38875552 | ||
Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma | Q39036358 | ||
Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. | Q39656557 | ||
The Intestinal Wnt/TCF Signature. | Q40167195 | ||
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity | Q40944056 | ||
Tissue- and stage-specific Wnt target gene expression is controlled subsequent to β-catenin recruitment to cis-regulatory modules | Q42269250 | ||
Actin microfilament aggregation induced by withaferin A is mediated by annexin II. | Q42489224 | ||
A withanolide coagulin-L inhibits adipogenesis modulating Wnt/β-catenin pathway and cell cycle in mitotic clonal expansion. | Q42810232 | ||
Biologically active withanolides from Withania coagulans | Q43653963 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0168170 | |
P577 | publication date | 2016-12-14 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells | |
P478 | volume | 11 |